[go: up one dir, main page]

NO20076444L - Gene-based algorithm-based cancer prognosis - Google Patents

Gene-based algorithm-based cancer prognosis

Info

Publication number
NO20076444L
NO20076444L NO20076444A NO20076444A NO20076444L NO 20076444 L NO20076444 L NO 20076444L NO 20076444 A NO20076444 A NO 20076444A NO 20076444 A NO20076444 A NO 20076444A NO 20076444 L NO20076444 L NO 20076444L
Authority
NO
Norway
Prior art keywords
gene
cancer prognosis
algorithm
gene expression
based algorithm
Prior art date
Application number
NO20076444A
Other languages
Norwegian (no)
Inventor
Christos Sotiriou
Mauro Delorenzi
Martine Piccart
Original Assignee
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/BE2006/000051 external-priority patent/WO2006119593A1/en
Application filed by Univ Bruxelles filed Critical Univ Bruxelles
Publication of NO20076444L publication Critical patent/NO20076444L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G01N33/575—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Den foreliggende oppfinnelsen angår fremgangsmåter og systemer for prognosebestemmelse i tumorprøver ved å måle genekspresjon i en tumorprøve og anvende en genekspresjonsgradindeks (GGI) eller tilbakefallspoengsum (RS) for å gi en numerisk risikopoengsum.The present invention relates to methods and systems for prognosis determination in tumor samples by measuring gene expression in a tumor sample and using a gene expression degree index (GGI) or relapse score (RS) to provide a numerical risk score.

NO20076444A 2005-05-13 2007-12-13 Gene-based algorithm-based cancer prognosis NO20076444L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68054305P 2005-05-13 2005-05-13
EP05447274 2005-12-07
PCT/BE2006/000051 WO2006119593A1 (en) 2005-05-13 2006-05-15 Gene-based algorithmic cancer prognosis

Publications (1)

Publication Number Publication Date
NO20076444L true NO20076444L (en) 2008-02-12

Family

ID=36613462

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076444A NO20076444L (en) 2005-05-13 2007-12-13 Gene-based algorithm-based cancer prognosis

Country Status (3)

Country Link
KR (1) KR20080064725A (en)
IL (1) IL187241A0 (en)
NO (1) NO20076444L (en)

Also Published As

Publication number Publication date
IL187241A0 (en) 2008-02-09
KR20080064725A (en) 2008-07-09

Similar Documents

Publication Publication Date Title
WO2008154098A3 (en) Reagents and methods for mirna expression analysis and identification of cancer biomarkers
DE602005009702D1 (en) ESR1 AND NUTRITIONAL CANCER
WO2007146819A3 (en) Methods for identifying and using snp panels
NO20074389L (en) Determination of responders to chemotherapy
ATE530911T1 (en) BINDING PROTEINS AS BIOSENSORS
BRPI1013688A8 (en) IL-17 BINDING PROTEINS.
WO2007095644A3 (en) Reagents and methods for cancer prognosis and pathological staging
ATE408828T1 (en) METHOD FOR DETECTING OVARIAL CARCINOMA
ATE513216T1 (en) USE OF THE PROTEIN SATB2 AS A PROGNOSTIC MARKER FOR COLORECTAL CARCINOMA
ATE471512T1 (en) USE OF PROTEIN S100A 12 AS A MARKER FOR COLORECTAL CARCINOMA
GB2451985A (en) Sepsis detection microarray
WO2011132061A3 (en) Methylation profiling of dna samples
ATE501267T1 (en) APOLIPOPROTEIN A-II ISOFORM AS A BIOMARKER FOR PROSTATE CANCER
WO2009019367A3 (en) Apolipoprotein ai assay method for the in vitro diagnosis of colorectal cancer
DE602005001302D1 (en) DETERMINATION OF ANALYTIC CHARACTERISTICS BASED ON BINDING CHARACTERISTICS
WO2012154567A3 (en) Human invasion signature for prognosis of metastatic risk
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
WO2010127417A3 (en) Hepatocellular carcinoma
WO2019139980A8 (en) Methods for measuring analyte and/or protein in biological samples
WO2015091575A3 (en) Different levels in blood cell samples of emt-markers for the diagnosis of cancer, in particular of colorectal (crc) and pancreatic (pc) cancer
WO2008063655A3 (en) Dna methylation markers and methods of use
DE602007006671D1 (en) USE OF NNMT AS A MARKER FOR LUNG CANCER
ATE545867T1 (en) I-PLASTIN TEST METHOD FOR IN VITRO DIAGNOSIS OF COLORECTAL CARCINOMA
WO2006133923A3 (en) Diagnosis, prognosis and prediction of recurrence of breast cancer
ATE462803T1 (en) KIT AND METHOD FOR DETECTING UROTHELIC CARCINOMA

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application